Easton Pharmaceuticals Inc. has entered into an Agreement to acquire an interest in a Real Estate Development Project just outside of Toronto, with 3 year cumulative profits expected to exceed CAD 30,000,000. As part of its plan to enter more lucrative market segments, Easton has signed an agreement with 2315446 Ontario Inc. to acquire an interest in a development property in Cobourg, Ontario, a growing lakefront community east of Toronto. The property is approximately 2.5 acres and is zoned for a multi-residential development to allow up to 48 units. The company intends on building 42 residential condominium units over the next 3 years, with the first phase approved and ready for 6 units in the existing building. The cumulative profits are expected to be in excess of CAD 30 million, of which Easton will retain approximately 50%. The profits of the first phase are expected to be in excess of CAD 2 million. The units are of varying sizes between 800 sq. ft. to over 2,500 sq. ft. The market is very strong among professional couples re-locating outside of the City, young families, as well as retirees, all seeking a better quality of life.